Dec 11, 2012 by Brenton Flynn and Max MacalusoThe Best of 2012: XOMADespite crashing by over 75% in 2011, XOMA is up 165% this year, putting it at #20 on our list of the very best healthcare stocks for investors in 2012.
Dec 10, 2012 by Brenton Flynn and Max MacalusoCelldex Soars After Exciting Phase 2 DataCelldex's new drug uses an advanced new delivery system to reach tumors, and investors are pleased; the stock is up 20% today.
Dec 10, 2012 by Brenton Flynn and Max MacalusoZogenix Gets the Thumbs-DownFriday's FDA advisory committee ruling against Zogenix's painkiller Zohydro has caused shares to tank.
Dec 7, 2012 by Brenton Flynn and Max MacalusoThe Worst of 2012: MAKO SurgicalMedical robot company MAKO Surgical makes No. 10 on our list of the very worst stocks in the healthcare sector this year.
Dec 7, 2012 by Brenton Flynn and Max MacalusoThis Blockbuster Drug Gets a Green LightA new approval for Bristol-Myers Squibb means important access to the UK market for its arthritis drug. But can the company shake a few persistent old problems?
Dec 7, 2012 by Brenton Flynn and Max MacalusoJohnson & Johnson: New Leader, New BlockbustersJohnson & Johnson is passing the torch to a new chairman.
Dec 7, 2012 by Brenton Flynn and Max MacalusoThis Top Big Pharma Stock Just Got an UpgradeMoody's just upgraded this diabetes juggernaut's already sublime credit rating.
Dec 7, 2012 by Brenton Flynn and Max MacalusoAnother Big Pharma Goes After Alzheimer'sAn historically difficult area to treat, big names are competing to be the first to crack the Alzheimer's code. Here's the newest big name on that list.
Dec 7, 2012 by Brenton Flynn and Max MacalusoThe Next Big Drugs to Keep Our... Ear On?The next hot drug area may surprise you.
Dec 7, 2012 by Brenton Flynn and Max MacalusoThe Worst of 2012: ArQuleLosing a staggering 52.8% of its share price this year, pharmaceutical company ArQule is No. 6 on our list of the very worst healthcare stocks of 2012.
Dec 7, 2012 by Brenton Flynn and Max MacalusoThe Worst of 2012: Quality SystemsThe first company on our list that's down over 50% this year, with a loss of 50.8% is Quality Systems, in at #7 on our list of the very worst health care stocks of the year.
Dec 7, 2012 by Brenton Flynn and Max MacalusoThe Worst of 2012: Accretive HealthWith a 48.1% loss this year, Accretive Health lands at No. 8 on our countdown of the very worst healthcare stocks of 2012.
Dec 7, 2012 by Brenton Flynn and Max MacalusoThe Worst of 2012: Delcath SystemsDelcath's drop of 47.2% puts it at No. 9 on our list of the very worst healthcare stocks of the year.
Dec 5, 2012 by Brenton Flynn and Max MacalusoThe Worst of 2012: Questcor PharmaceuticalsAt No. 21 on our list of the very worst healthcare stocks of 2012, Questcor Pharmaceuticals.
Dec 5, 2012 by Brenton Flynn and Max MacalusoThe Worst of 2012: Horizon PharmaceuticalsAs we continue the countdown of the worst stocks in healthcare for 2012, we look at No. 22 on the list, Horizon Pharmaceuticals.
Dec 5, 2012 by Brenton Flynn and Max MacalusoThe Worst of 2012: Universal AmericanUniversal American Corporation is No. 23 on our list of the worst healthcare stocks of 2012.
Dec 5, 2012 by Brenton Flynn and Max MacalusoThe Worst of 2012: Halozyme TherapeuticsA look at the very worst healthcare stocks this year. At No. 24, Halozyme Therapeutics.
Dec 5, 2012 by Brenton Flynn and Max MacalusoThe Worst of 2012: Trius TherapeuticsTrius Therapeutics kicks off our naughty list for the worst health care stocks of 2012.
Dec 4, 2012 by Brenton Flynn and Max Macaluso1 Health-Care Stock for the Special Dividend SpreeThis major operator of health-care facilities is paying out yet another special dividend.
Dec 4, 2012 by Brenton Flynn and Max MacalusoWhat's Driving This Biotech Stock Through the Roof?With shares up more than 50% over the past five trading sessions on largely no news, what does this biotech have up its sleeve?
